Fyn gene silencing reduces oligodendrocytes apoptosis through inhibiting ERK1/2 phosphorylation in epilepsy

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Oligodendrocytes (OLs) are crucial for neuronal function and survival.
• Epilepsy can lead to oligodendrocyte damage and apoptosis, contributing to neurological deficits.
• The role of Fyn kinase in oligodendrocyte apoptosis during epilepsy is not fully understood.

Purpose of the Study:

• To investigate the effect of Fyn gene silencing on oligodendrocyte apoptosis in an in vitro epilepsy model.
• To elucidate the underlying mechanism involving the ERK1/2 signaling pathway.

Main Methods:

• Primary rat oligodendrocyte progenitor cells (OPCs) were differentiated into OLs.
• Fyn gene silencing was achieved using small interfering RNA (si-Fyn3).
• An in vitro epilepsy model was induced by culturing cells in Mg-free extracellular fluid.
• Apoptosis was assessed by flow cytometry, and protein expression (Fyn, ERK1/2, p-ERK1/2) was analyzed by Western blot.

Main Results:

• Epilepsy model and negative control groups showed significantly increased oligodendrocyte apoptosis, Fyn expression, and p-ERK1/2/ERK1/2 ratio compared to controls.
• Fyn gene silencing (si-Fyn3) markedly reduced oligodendrocyte apoptosis and decreased Fyn expression and p-ERK1/2/ERK1/2 ratio compared to the epilepsy model group.
• These results indicate that Fyn kinase activity is elevated in the epilepsy model and contributes to OL apoptosis.

Conclusions:

• Fyn gene silencing effectively reduces oligodendrocyte apoptosis in an in vitro epilepsy model.
• The mechanism involves the inhibition of ERK1/2 phosphorylation by Fyn.
• Targeting Fyn kinase may represent a therapeutic strategy to protect oligodendrocytes in epilepsy.